| scholarly article | Q13442814 |
| P50 | author | Graeme Meintjes | Q55098484 |
| Joseph N. Jarvis | Q55128238 | ||
| Thomas Harrison | Q59550918 | ||
| Robin Wood | Q60590121 | ||
| P2860 | cites work | Effectiveness of Antiretroviral Treatment in a South African Program A Cohort Study | Q57343454 |
| Determinants of Mortality and Nondeath Losses from an Antiretroviral Treatment Service in South Africa: Implications for Program Evaluation | Q58042135 | ||
| Fungal Burden, Early Fungicidal Activity, and Outcome in Cryptococcal Meningitis in Antiretroviral-Naive or Antiretroviral-Experienced Patients Treated with Amphotericin B or Fluconazole | Q59115058 | ||
| Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model | Q29305377 | ||
| Mortality and loss-to-follow-up during the pre-treatment period in an antiretroviral therapy programme under normal health service conditions in Uganda | Q33492607 | ||
| High ongoing burden of cryptococcal disease in Africa despite antiretroviral roll out | Q33854516 | ||
| Efficacy of antiretroviral therapy adherence interventions: a research synthesis of trials, 1996 to 2004. | Q36422805 | ||
| Adherence to antiretroviral therapy in sub-Saharan Africa and North America: a meta-analysis | Q36560027 | ||
| Provision of antiretroviral therapy in South Africa: unique challenges and remaining obstacles | Q37053040 | ||
| Antiretroviral therapy and early mortality in South Africa | Q37113094 | ||
| The changing epidemiology of cryptococcosis: an update from population-based active surveillance in 2 large metropolitan areas, 1992-2000. | Q46172301 | ||
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | South Africa | Q258 |
| anti-retroviral agent | Q50430310 | ||
| P304 | page(s) | 1233-1235 | |
| P577 | publication date | 2010-05-01 | |
| P1433 | published in | AIDS | Q4651863 |
| P1476 | title | Testing but not treating: missed opportunities and lost lives in the South African antiretroviral therapy programme | |
| P478 | volume | 24 |
| Q36806209 | Adjunctive interferon-γ immunotherapy for the treatment of HIV-associated cryptococcal meningitis: a randomized controlled trial |
| Q37086356 | Attrition from HIV testing to antiretroviral therapy initiation among patients newly diagnosed with HIV in Haiti |
| Q37215923 | Comparison of cryptococcal antigenemia between antiretroviral naïve and antiretroviral experienced HIV positive patients at two hospitals in Ethiopia |
| Q28534733 | Cost effectiveness of cryptococcal antigen screening as a strategy to prevent HIV-associated cryptococcal meningitis in South Africa |
| Q36543833 | Cryptococcal Antigen Screening in Patients Initiating ART in South Africa: A Prospective Cohort Study |
| Q35880502 | Cryptococcal Antigenemia in Immunocompromised Human Immunodeficiency Virus Patients in Rural Tanzania: A Preventable Cause of Early Mortality |
| Q40055779 | Cryptococcal antigen screening by lay cadres using a rapid test at the point of care: A feasibility study in rural Lesotho. |
| Q38098090 | Cryptococcal infections: changing epidemiology and implications for therapy. |
| Q37351578 | Diagnosis of Cryptococcosis and Prevention of Cryptococcal Meningitis Using a Novel Point-of-Care Lateral Flow Assay |
| Q35353193 | Evaluation of a novel point-of-care cryptococcal antigen test on serum, plasma, and urine from patients with HIV-associated cryptococcal meningitis |
| Q28078958 | HIV-Associated Cryptococcal Meningitis: Bridging the Gap Between Developed and Resource-Limited Settings |
| Q24610933 | Integrating cryptococcal antigen screening and pre-emptive treatment into routine HIV care |
| Q34516367 | Long term 5-year survival of persons with cryptococcal meningitis or asymptomatic subclinical antigenemia in Uganda |
| Q33578341 | Missed opportunities for retention in pre-ART care in Cape Town, South Africa |
| Q37014032 | One in 4 HIV-Positive South Africans Awaiting ART Initiation Report Condomless Sex With a Serodiscordant Partner |
| Q37929748 | Preventing deaths from cryptococcal meningitis: from bench to bedside |
| Q34064710 | Stigmatising attitudes among people offered home-based HIV testing and counselling in Blantyre, Malawi: construction and analysis of a stigma scale |
| Q34506072 | Who starts? Factors associated with starting antiretroviral therapy among eligible patients in two, public HIV clinics in Lilongwe, Malawi |
Search more.